TC Biopharm (TCBP) Stock Chart & Stock Price History → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free TCBP Stock Alerts $1.49 -0.04 (-2.61%) (As of 04/29/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial Media TC Biopharm Stock Price Performance5 Day Performance-5.10%1 Month Performance+13.74%3 Month Performance+26.27%6 Month Performance-98.27%Year-To-Date Performance-53.00%1 Year Performance-99.33% Receive TCBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TC Biopharm and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. TCBP Stock Chart for Tuesday, April, 30, 2024 TCBP Chart by TradingView TC Biopharm Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/29/2024$1.53$1.49-2.61%$1.60$1.4964,482 shs$1.01 million04/26/2024$1.57$1.53-2.55%$1.63$1.5171,629 shs$1.04 million04/25/2024$1.47$1.57+6.80%$1.65$1.49143,139 shs$1.07 million04/24/2024$1.58$1.47-6.96%$1.62$1.44113,778 shs$1 million04/23/2024$1.58$1.58$1.67$1.54113,160 shs$1.07 million04/22/2024$1.48$1.58+6.83%$1.60$1.49132,859 shs$1.07 million Get the Latest News and Ratings for TCBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TC Biopharm and its competitors with MarketBeat's FREE daily newsletter. 04/19/2024$1.42$1.48+4.15%$1.49$1.3883,766 shs$1.01 million04/18/2024$1.35$1.42+5.19%$1.52$1.37172,818 shs$961,000.0004/17/2024$1.33$1.35+1.50%$1.38$1.3075,285 shs$918,000.0004/16/2024$1.31$1.33+1.53%$1.35$1.27113,603 shs$904,000.0004/15/2024$1.61$1.31-18.63%$1.54$1.30367,605 shs$891,000.0004/12/2024$1.74$1.61-7.47%$1.75$1.61154,509 shs$1.10 million04/11/2024$1.70$1.74+2.35%$1.75$1.66108,450 shs$1.18 million04/10/2024$1.86$1.70-8.60%$1.79$1.60317,181 shs$1.16 million04/09/2024$1.78$1.86+4.49%$1.98$1.64440,110 shs$1.26 million04/08/2024$1.90$1.78-6.32%$1.90$1.65503,805 shs$1.21 million04/05/2024$1.95$1.90-2.56%$2.01$1.761.52 million shs$1.29 million04/04/2024$1.30$1.95+50.00%$3.27$1.8287.66 million shs$1.32 million04/03/2024$1.27$1.30+2.36%$1.31$1.25139,408 shs$884,000.0004/02/2024$1.27$1.27$1.33$1.24198,866 shs$864,000.0004/01/2024$1.31$1.27-3.05%$1.33$1.18281,431 shs$864,000.0003/29/2024$1.31$1.31$1.49$1.30413,934 shs$887,000.0003/28/2024$1.43$1.31-8.39%$1.49$1.30377,108 shs$891,000.0003/27/2024$1.41$1.43+1.42%$1.52$1.35373,064 shs$972,000.0003/26/2024$1.43$1.41-1.40%$1.49$1.40190,989 shs$959,000.0003/25/2024$1.52$1.43-5.92%$1.59$1.43225,745 shs$972,000.0003/22/2024$1.62$1.52-6.17%$1.64$1.48221,530 shs$1.03 million03/21/2024$1.54$1.62+5.19%$1.68$1.45865,804 shs$1.10 million03/20/2024$1.46$1.54+5.48%$1.59$1.361.23 million shs$1.05 million03/19/2024$1.62$1.46-9.88%$1.52$1.42325,090 shs$988,000.0003/18/2024$1.68$1.62-3.57%$1.69$1.32801,733 shs$1.10 million03/15/2024$1.92$1.68-12.50%$1.93$1.59623,574 shs$1.14 million03/14/2024$1.70$1.92+12.94%$2.05$1.771.40 million shs$1.30 million03/13/2024$1.80$1.70-5.56%$1.98$1.501.52 million shs$1.16 million03/12/2024$1.71$1.80+5.26%$2.25$1.738.52 million shs$1.22 million03/11/2024$1.06$1.71+61.32%$3.17$1.55139.17 million shs$1.16 million03/08/2024$1.04$1.06+1.92%$1.12$1.0596,256 shs$721,000.0003/07/2024$1.05$1.04-0.95%$1.15$1.03184,218 shs$707,000.0003/06/2024$1.26$1.05-16.67%$1.18$0.87657,460 shs$714,000.0003/05/2024$1.26$1.26$1.29$1.21134,007 shs$853,000.00Charles Payne’s Gift to Stock Investors (Ad)Right now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.Watch Insider's Advantage Event Tuesday at 4:00 PM ET03/04/2024$1.33$1.26-5.26%$1.36$1.24204,484 shs$857,000.0003/01/2024$1.27$1.33+4.72%$1.35$1.27215,583 shs$904,000.0002/29/2024$1.35$1.27-5.58%$1.33$1.21241,637 shs$864,000.0002/28/2024$1.27$1.35+5.91%$1.37$1.21468,907 shs$915,000.0002/27/2024$1.21$1.27+4.96%$1.33$1.19440,944 shs$864,000.0002/26/2024$1.05$1.21+15.24%$1.26$1.04997,100 shs$823,000.0002/23/2024$1.22$1.05-13.93%$1.22$1.01439,758 shs$714,000.0002/22/2024$1.09$1.22+11.94%$1.42$1.071.34 million shs$830,000.0002/21/2024$1.16$1.09-6.04%$1.13$1.0898,021 shs$741,000.0002/20/2024$1.08$1.16+7.41%$1.16$1.01456,334 shs$785,000.0002/19/2024$1.08$1.08$1.09$0.99272,400 shs$734,000.0002/16/2024$1.03$1.08+4.85%$1.09$0.99257,957 shs$734,000.0002/15/2024$1.04$1.03-0.96%$1.09$1.01226,407 shs$697,000.0002/14/2024$1.21$1.04-14.05%$1.17$1.02356,538 shs$707,000.0002/13/2024$1.09$1.21+11.01%$1.28$0.961.05 million shs$823,000.0002/12/2024$1.52$1.09-28.29%$1.41$1.021.81 million shs$741,000.0002/09/2024$1.10$1.52+38.18%$1.74$1.3322.27 million shs$1.03 million02/08/2024$0.94$1.10+16.91%$1.23$0.931.08 million shs$748,000.0002/07/2024$0.97$0.94-2.80%$0.97$0.9158,880 shs$640,000.0002/06/2024$0.89$0.97+9.38%$0.98$0.87124,597 shs$658,000.0002/05/2024$0.96$0.89-7.81%$0.94$0.85158,269 shs$599,000.0002/02/2024$1.07$0.96-10.13%$1.08$0.94253,506 shs$654,000.0002/01/2024$1.09$1.07-1.83%$1.10$1.0398,942 shs$728,000.0001/31/2024$1.18$1.09-7.63%$1.17$1.05420,637 shs$741,000.0001/30/2024$1.23$1.18-4.07%$1.21$1.11411,934 shs$802,000.0001/29/2024$1.42$1.23-13.38%$1.31$1.111.00 million shs$836,000.00 Related Companies: Scinai Immunotherapeutics Stock Price Chart Acorda Therapeutics Stock Price Chart SQZ Biotechnologies Stock Price Chart Acorda Therapeutics Stock Price Chart Gamida Cell Stock Price Chart Eloxx Pharmaceuticals Stock Price Chart Avalon GloboCare Stock Price Chart Gamida Cell Stock Price Chart Kiromic BioPharma Stock Price Chart TRACON Pharmaceuticals Stock Price Chart Receive TCBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TC Biopharm and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCBP) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 Media4 coins to be the “Next Bitcoin”True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.